Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease

Martina Gabrielli1, Ilaria Prada1, Pooja Joshi1

  • 1CNR Institute of Neuroscience, Vedano al Lambro, MB 20854, Italy.

Insights

Microglia-released amyloid-beta extracellular vesicles (Aβ-EVs) drive early Alzheimer's synaptic dysfunction. Their movement along neurons spreads impairments, offering new therapeutic targets for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Alzheimer's Disease Research

Background:

  • Synaptic dysfunction is an early Alzheimer's disease (AD) hallmark, but its initiation and spread remain unclear.
  • Microglial dysfunction and amyloid-beta (Aβ) accumulation are key in AD pathogenesis.

Purpose of the Study:

  • To investigate the role of microglial extracellular vesicles (EVs) carrying Aβ in initiating and propagating synaptic dysfunction in Alzheimer's disease.
  • To elucidate the mechanism by which Aβ-EVs spread synaptic impairments within neural circuits.

Main Methods:

  • In vitro and in vivo studies using mouse models.
  • Amyloid-beta extracellular vesicle (Aβ-EV) injection into the mouse entorhinal cortex.
  • Assessment of long-term potentiation (LTP) in the entorhinal cortex-dentate gyrus circuitry.
  • Optical tweezers and time-lapse imaging to track Aβ-EV-neuron interactions.
  • Inhibition of Aβ-EV motility using annexin-V coating.

Main Results:

  • Aβ-EVs altered dendritic spine morphology in vitro and impaired synaptic plasticity (LTP) both in vitro and in vivo.
  • LTP deficits spread from the entorhinal cortex to the dentate gyrus within 24 hours post-injection.
  • Aβ-EVs exhibited anterograde motion along neuronal axons, and inhibiting this motility prevented LTP deficit propagation.
  • Neither Aβ42 alone nor non-amyloid inflammatory EVs caused similar propagation of synaptic impairment.

Conclusions:

  • Large microglial extracellular vesicles carrying amyloid-beta are implicated in the onset and spread of early synaptic dysfunction in Alzheimer's disease.
  • The anterograde motility of Aβ-EVs along neuronal surfaces is a critical mechanism for the propagation of synaptic impairments.
  • Targeting Aβ-EVs and their movement presents a novel therapeutic strategy to delay Alzheimer's disease progression.